These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 335584)

  • 1. Immunosuppression with polyunsaturated fatty acids in renal transplantation.
    McHugh MI; Wilkinson R; Elliott RW; Field EJ; Dewar P; Hall RR; Taylor RM; Uldall PR
    Transplantation; 1977 Oct; 24(4):263-7. PubMed ID: 335584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis.
    Bates D; Fawcett PR; Shaw DA; Weightman D
    Br Med J; 1978 Nov; 2(6149):1390-1. PubMed ID: 363236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids and multiple sclerosis.
    Bates D
    Biochem Soc Trans; 1989 Apr; 17(2):289-91. PubMed ID: 2546837
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Unsaturated fatty acids and renal transplantation.
    Mertin J
    Lancet; 1974 Sep; 2(7882):717. PubMed ID: 4142984
    [No Abstract]   [Full Text] [Related]  

  • 5. Dietary fish oil does not influence acute rejection rate and graft survival after renal transplantation: a randomized placebo-controlled study.
    Hernández D; Guerra R; Milena A; Torres A; García S; García C; Abreu P; González A; Gómez MA; Rufino M; González-Posada J; Lorenzo V; Salido E
    Nephrol Dial Transplant; 2002 May; 17(5):897-904. PubMed ID: 11981081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyunsaturated fatty acids and colchicine in multiple sclerosis.
    Br Med J; 1979 Feb; 1(6160):411-2. PubMed ID: 761034
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
    Nashan B; Moore R; Amlot P; Schmidt AG; Abeywickrama K; Soulillou JP
    Lancet; 1997 Oct; 350(9086):1193-8. PubMed ID: 9652559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of diltiazem on renal function and rejection in renal allograft recipients receiving triple-drug immunosuppression: a randomized, double-blind, placebo-controlled study.
    Ladefoged SD; Pedersen E; Hammer M; Rasmussen KC; Hansen FM; Andersen CB
    Nephrol Dial Transplant; 1994; 9(5):543-7. PubMed ID: 8090335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group.
    Nashan B; Light S; Hardie IR; Lin A; Johnson JR
    Transplantation; 1999 Jan; 67(1):110-5. PubMed ID: 9921806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. n-3 fatty acids of marine origin lower systolic blood pressure and triglycerides but raise LDL cholesterol compared with n-3 and n-6 fatty acids from plants.
    Kestin M; Clifton P; Belling GB; Nestel PJ
    Am J Clin Nutr; 1990 Jun; 51(6):1028-34. PubMed ID: 1971991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Unsaturated fatty acids and renal transplantation.
    Uldall PR; Wilkinson R; McHugh MI; Field EJ; Shenton BK; Taylor RM; Swinney J
    Lancet; 1974 Aug; 2(7879):514. PubMed ID: 4137027
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma levels of marine n-3 polyunsaturated fatty acids and renal allograft survival.
    Eide IA; Jenssen T; Hartmann A; Diep LM; Dahle DO; Reisæter AV; Bjerve KS; Christensen JH; Schmidt EB; Svensson M
    Nephrol Dial Transplant; 2016 Jan; 31(1):160-7. PubMed ID: 26410884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of n-3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients: a randomized placebo-controlled study.
    Busnach G; Stragliotto E; Minetti E; Perego A; Brando B; Broggi ML; Civati G
    J Nephrol; 1998; 11(2):87-93. PubMed ID: 9589380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.
    Clark G; Walsh G; Deshpande P; Koffman G
    Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of basiliximab for immunoprophylaxis in renal transplantation.
    Keown P; Balshaw R; Khorasheh S; Chong M; Marra C; Kalo Z; Korn A
    BioDrugs; 2003; 17(4):271-9. PubMed ID: 12899644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind evaluation of evening primrose oil as an antiobesity agent.
    Haslett C; Douglas JG; Chalmers SR; Weighhill A; Munro JF
    Int J Obes; 1983; 7(6):549-53. PubMed ID: 6360923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Linoleic acid and transplantation.
    Uldall PR; Wilkinson R; McHugh MI; Field EJ; Shenton BK; Baxby K; Taylor RM
    Lancet; 1975 Jul; 2(7925):128-9. PubMed ID: 49719
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical research council trial of antilymphocyte globulin in renal transplantation. A multicenter randomized double-blind placebo controlled clinical investigation.
    Bell PR; Blamey RW; Briggs JD; Castro JE; Hamilton DN; Knapp MS; Salaman JR; Sells RA; Williams G; Gowans JL; Peto R; Richards S; Phillips AW; Weinberg AL; Freestone DS
    Transplantation; 1983 Jun; 35(6):539-45. PubMed ID: 6346595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal transplantation after failure of a first graft.
    Waltzer WC; Zincke H; Sterioff S; Offord KP; Frohnert PP
    Surg Gynecol Obstet; 1981 Apr; 152(4):476-82. PubMed ID: 7010644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebo-controlled study.
    Bennett WM; Carpenter CB; Shapiro ME; Strom TB; Hefty D; Tillman M; Abrams J; Ryan D; Kelley VR
    Transplantation; 1995 Feb; 59(3):352-6. PubMed ID: 7871564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.